Omission of Throat Anesthesia Using Jackson's Spray Prior to Bronchoscopy for Preventing Aerosol Generation: A Survey Through Patient Distress Questionnaire.

aerosol bronchoscopy covid-19 jackson’s spray questionnaire throat anesthesia

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Aug 2021
Historique:
accepted: 16 08 2021
entrez: 20 9 2021
pubmed: 21 9 2021
medline: 21 9 2021
Statut: epublish

Résumé

Background and objective Due to the outbreak of coronavirus disease 2019 (COVID-19), the Japanese Society of Respiratory Endoscopy recommended the omission of throat anesthesia using Jackson's spray prior to bronchoscopy for preventing aerosol generation. In this survey, we investigated the tolerability of patients toward the omission of anesthesia using Jackson's spray before bronchoscopy. Methods Group A patients received throat anesthesia with 5 mL of 4% lidocaine using Jackson's spray prior to bronchoscopy and were then administered pethidine hydrochloride and midazolam intravenously. Group B patients did not receive anesthesia using Jackson's spray before bronchoscopy. They were administered pethidine hydrochloride and midazolam and were then administered 8% lidocaine several times into the pharynx. A patient distress questionnaire, classified as a five-graded score, was administered to each group after bronchoscopy. Results Seventy patients participated in this study: 39 patients in Group A and 31 patients in Group B. There were no significant differences in their backgrounds. In the questionnaire survey, the distress caused by pre-examination anesthesia in Group A was significantly higher than in Group B (3.03 ± 1.25 vs. 1.23 ± 0.62;

Identifiants

pubmed: 34540458
doi: 10.7759/cureus.17231
pmc: PMC8442806
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e17231

Informations de copyright

Copyright © 2021, Murata et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Chest. 2005 Sep;128(3):1756-60
pubmed: 16162784
Chest. 2011 Nov;140(5):1342-1350
pubmed: 22045879
Thorax. 2013 Aug;68 Suppl 1:i1-i44
pubmed: 23860341
Ann Intern Med. 2021 Jan;174(1):69-79
pubmed: 32941052

Auteurs

Saori Murata (S)

Department of Pulmonary Medicine, Tokyo Saiseikai Central Hospital, Tokyo, JPN.

Shinji Sasada (S)

Department of Pulmonary Medicine, Tokyo Saiseikai Central Hospital, Tokyo, JPN.

Yusuke Usui (Y)

Department of Pulmonary Medicine, Tokyo Saiseikai Central Hospital, Tokyo, JPN.

Tetsuya Sakai (T)

Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, JPN.

Keisuke Kirita (K)

Department of Pulmonary Medicine, Tokyo Saiseikai Central Hospital, Tokyo, JPN.

Kota Ishioka (K)

Department of Pulmonary Medicine, Tokyo Saiseikai Central Hospital, Tokyo, JPN.

Saeko Takahashi (S)

Department of Pulmonary Medicine, Tokyo Saiseikai Central Hospital, Tokyo, JPN.

Morio Nakamura (M)

Department of Pulmonary Medicine, Tokyo Saiseikai Central Hospital, Tokyo, JPN.

Classifications MeSH